New Mast Cell Lines from Patients with Systemic Mastocytosis

Overview

About this study

The purpose of this study is to attempt to establish new mast cell lines from patients with systemic mastocytosis using peripheral blood and/or bone marrow.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:       

  • Mastocytosis

Exclusion Criteria:      

  • No diagnosis of mastocytosis

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Joseph Butterfield, M.D.

Open for enrollment

Contact information:

Joseph Butterfield M.D.

(507)284-3544

butterfield.joseph@mayo.edu

More information

Publications

Publications are currently not available